Active, Not Recruiting
A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV
NCT06970223
- Conditions
- Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +17 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States